LabCorp(R) Acquires ViroMed Inc.

BURLINGTON, N.C., June 4 /PRNewswire/ -- Laboratory Corporation of America Holdings (NYSE: LH) (LabCorp(R)) today announced that it has completed the acquisition of Minneapolis-based ViroMed Inc. ViroMed had clinical laboratory revenues for the twelve months ended December 31, 2000 of approximately

Roche to Sell Up to 6.0 Million Shares of LabCorp

BURLINGTON, N.C., May 10 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the offering by Roche Holdings, Inc.

LabCorp(R) Scheduled to Present at Deutsche Banc Alex. Brown Health Care Conference

BURLINGTON, N.C., May 8 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Deutsche Banc Alex. Brown Health Care Conference in Baltimore, MD on Tuesday,

Laboratory Corporation of America(R) Completes Acquisition of Path Lab

BURLINGTON, N.C., May 1 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (NYSE: LH) (LabCorp(R)) today announced that it has completed the acquisition of New England-based Path Lab Holdings, Inc. (Path Lab). Path Lab had revenues in 2000 of approximately $51.6 million and earnings

Laboratory Corporation of America(R) Announces First Quarter Results

Reports Record Profits Driven by Strong Sales; Announces Two-for-One Stock Split BURLINGTON, N.C., April 23 /PRNewswire Interactive News Release/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2001.

LabCorp(R) Scheduled to Present at the Merrill Lynch Health Services Conference

BURLINGTON, N.C., April 11 /PRNewswire/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Merrill Lynch Health Services Conference in Washington, DC on Wednesday,

LabCorp® Scheduled to Present at Thomas Weisel Healthcare Conference

Burlington, NC, April 3, 2001 -- Laboratory Corporation of America® Holdings (LabCorp® ) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of public affairs, is scheduled to speak at the Thomas Weisel Healthcare Conference in San Francisco on April 3.

Labcorp® Scheduled To Present At Banc Of America

Burlington, NC, March 27, 2001 -- Laboratory Corporation of America® Holdings (LabCorp®)(NYSE: LH) today announced that Thomas P. Mac Mahon, chairman and chief executive officer, is scheduled to speak at the Banc of America Securities Health Care Conference in Las Vegas on March 27.

Laboratory Corporation of America® Announces Definitive Agreement to Acquire Path Lab in New England

Burlington, NC, March 26, 2001 -- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that it has entered into a definitive agreement with privately-held Path Lab Holdings, Inc. (Path Lab) to acquire all of its outstanding stock.

LABCORP® INTRODUCES HIV GENOSURE(TM), A NEW HIV GENOTYPIC RESISTANCE ASSAY

Contact: 336-436-4855 Pamela Sherry Shareholder Direct: 800-LAB-0401 www.labcorp.com LABCORP(R) INTRODUCES HIV GENOSURE(TM), A NEW HIV GENOTYPIC RESISTANCE ASSAY Burlington, NC, December 12, 2000 - Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the